MAP3K7IP1 blocking peptide product blog
Tags: Blocking Peptide; TAB1; MAP3K7IP1 blocking peptide; MAP3K7IP1;
The MAP3K7IP1 tab1 (Catalog #MBS152945) is a Blocking Peptide and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s TAB1 can be used in a range of immunoassay formats including, but not limited to, Blocking (BL).TAB1 peptide is used for blocking the activity of the TAB1 antibody. Researchers should empirically determine the suitability of the MAP3K7IP1 tab1 for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The MAP3K7IP1 tab1 product has the following accession number(s) (GI #5174703) (NCBI Accession #NP_006107) (Uniprot Accession #Q15750). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Species: Human
Buffer: PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide
Location: 13 amino acids near the center of human TAB1. The following patways have been known to be associated with this gene. Carcinoma, Hepatocellular, Cardiovascular Diseases, Cell Transformation, Neoplastic, Inflammation, Ischemia, Liver Diseases, Liver Neoplasms, Myocardial Infarction, Necrosis, Neoplasm Metastasis are some of the diseases may be linked to TAB1 Peptide. Blood, Bone, Embryonic Tissue, Heart, Kidney, Liver, Lung, Muscle, Skin, Vascular tissues are correlated with this protein.